Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 15:17:2283-2296.
doi: 10.2147/CCID.S474331. eCollection 2024.

Effectiveness and Safety of a Dermocosmetic Cream as an Adjunct to Adapalene for Mild and Moderate Acne in Indonesia: Results of a Multicenter Randomized Controlled Study

Affiliations

Effectiveness and Safety of a Dermocosmetic Cream as an Adjunct to Adapalene for Mild and Moderate Acne in Indonesia: Results of a Multicenter Randomized Controlled Study

Irma Bernadette S Sitohang et al. Clin Cosmet Investig Dermatol. .

Abstract

Purpose: Acne is a chronic inflammatory skin condition affecting mainly teenagers and adults as well. Guidelines recommend retinoids as a first-line treatment for mild-to-moderate acne. However, dermocosmetics in adjunct could potentially improve efficacy and tolerability. This study was conducted to determine the effectiveness and safety of a dermocosmetic cream containing salicylic acid, lipohydroxy acid, niacinamide, Aqua posae filiformis, procerad and zinc salt in the treatment of mild-to-moderate acne vulgaris in adjunct to different regimens of adapalene compared to adapalene only.

Patients and methods: This randomized, controlled, parallel-group, evaluator-blind study was conducted over 8 weeks on male and female acne subjects at five teaching hospitals in Indonesia. A total of 291 participants were enrolled and divided into three treatment groups: Group A adapalene 0.1% cream nightly - Group B dermocosmetic cream daily + adapalene 0.1% cream every two nights - Group C dermocosmetic cream daily + adapalene 0.1% cream nightly. Clinical evaluations of treatment included scoring on Global Evaluation of Acne (GEA) scale, lesion count (Indonesian Acne Expert Meeting scale), treatment tolerability and treatment satisfaction. Evaluations were performed on Day 28 and Day 56 of treatment.

Results: After 28 and 56 days of treatment, all groups exhibited improvements across the various measures. Data analysis, utilizing Anova for repeated measurements, revealed a statistically significant difference between Groups C and A for reduction of GEA scores (p = 0.038) in favor of Group C. On Day 56, percentages of subjects with GEA Scale improvements of at least 1 grade in comparison with baseline were in Group C (61.7%) followed by Group A (47.9%) and Group B (45.3%). Better treatment tolerance and satisfaction scores were noted in Groups B and C.

Conclusion: Combination of the dermocosmetic cream with adapalene showed higher efficacy, tolerability and satisfaction in comparison to adapalene alone.

Keywords: adjunct to Adapalene; dermocosmetic cream; mild and moderate acne vulgaris.

PubMed Disclaimer

Conflict of interest statement

Delphine Kerob is a full-time employee of La Roche Posay Laboratoire Dermatologique. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Group A: Adapalene 0.1% cream nightly.
Figure 2
Figure 2
Group B: combination cream daily and Adapalene 0.1% cream every two nights.
Figure 3
Figure 3
Group C: combination cream daily and Adapalene 0.1% cream nightly.
Figure 4
Figure 4
Comparative analysis of changes in GEA scores from baseline between the three groups over the 56-day experimental period. The reduction of GEA scores was numerically higher in Group C compared to A and B, and the statistical analysis showed a significant difference between Groups A and C on Day 28.
Figure 5
Figure 5
Comparative analysis of changes in inflammatory lesion count from baseline between the three groups over the 56-day experimental period. There was a trend towards a numerically higher reduction in Group C compared to A and B, although no statistically significant difference could be demonstrated (Mann–Whitney test) between the groups.

References

    1. Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016;7:13–25. PMID: 26955297; PMCID: PMC4769025. doi:10.2147/AHMT.S55832 - DOI - PMC - PubMed
    1. Layton AM, Thiboutot D, Tan J. Reviewing the global burden of acne: how could we improve care to reduce the burden? Br J Dermatol. 2021;184(2):219–225. PMID: 32770673. doi:10.1111/bjd.19477 - DOI - PubMed
    1. Sibero HT, Sirajudin A, Anggraini DI. Prevalensi dan gambaran epidemiologi akne vulgaris di Provinsi Lampung. JK Unila. 2019;3(2):308–312. Indonesian.
    1. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474–485. PMID: 23210645. doi:10.1111/bjd.12149 - DOI - PubMed
    1. Thiboutot DM, Dreno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from the global alliance to improve outcomes in acne. J Am Acad Dermatol. 2018;78(2):S1–S23. doi:10.1016/j.jaad.2017.09.078 - DOI - PubMed

LinkOut - more resources